3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Lung Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Breast Neoplasms
3
Stomach Neoplasms
2
Rectal Neoplasms
2
Pancreatic Neoplasms
2
Barrett Esophagus
2
Triple Negative Breast Neoplasms
1
Thyroid Nodule
1
Smoking Cessation
1
Small Cell Lung Carcinoma
1
Recurrence
1
Prostatic Neoplasms
1
Neoplastic Cells, Circulating
1
Neoplasms
1
Neoplasm Metastasis
1
Multiple Pulmonary Nodules
1
Lung Diseases
1
Hypoxia
1
Head and Neck Neoplasms
1
Gastrointestinal Neoplasms
1
Fallopian Tube Neoplasms
1
Esophageal Neoplasms
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Cardiotoxicity
1
Carcinoma, Ovarian Epithelial
1
Carcinoma
1
Breast Neoplasm Female
1
Adenocarcinoma of Lung
1
Interventions
palbociclib
2
Letrozole
2
Fulvestrant
2
Anastrozole
2
venetoclax
1
pyrotinib
1
pertuzumab
1
penpulimab
1
dalpiciclib
1
anlotinib
1
Tretinoin
1
Trastuzumab
1
Ropivacaine
1
Radiosurgery
1
Propofol
1
Paclitaxel
1
Ondansetron
1
Morphine
1
Induction Chemotherapy
1
Etoricoxib
1
Docetaxel
1
Diagnostic Imaging
1
Carboplatin
1
Capecitabine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Breast Neoplasm Female
×
Diagnostic Imaging
×
Clear all
NCT03217539
2018-02-07
WE
Dalarna County Council, Sweden
Phase NA
Completed
133,065 enrolled